Article Details
Retrieved on: 2018-05-09 00:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Meanwhile, GlaxoSmithKline tapped <b>Insilico Medicine</b> to use AI, genomics and big data to help identify novel biological targets and pathways last August. Insilico's own drug discovery programs have focused on cancer, ALS and diabetes, as well as in Parkinson's and Alzheimer's disease. And this week ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here